Artron Lab Antibody Test Sars-Cov2 Price

LAB Antibody

ABD13143 100 ug
EUR 525.6

Artron Lab Laboratories manufactures the artron lab antibody test sars-cov2 price reagents distributed by Genprice. The Artron Lab Antibody Test Sars-Cov2 Price reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Artron Lab. Other Artron products are available in stock. Specificity: Artron Category: Lab Group: Antibody Test

Lab 170250F

5mg Ask for price
Description: Lab 170250F

LAB 149202F

10mg Ask for price
Description: LAB 149202F

LAB 149202F

1g Ask for price
Description: LAB 149202F

LAB 149202F

1mg Ask for price
Description: LAB 149202F

LAB 149202F

50mg Ask for price
Description: LAB 149202F

LAB 149202F

5mg Ask for price
Description: LAB 149202F

NATL/LAB Antibody

each
EUR 379.2

Antibody Test information

Mouse Monoclonal Antibody to SARS-Cov2-NP3

E10-31927 100 μl
EUR 275
Description: Available in various conjugation types.

Mouse Monoclonal Antibody to SARS-Cov2-NP3

E10-31928 100 μl
EUR 275
Description: Available in various conjugation types.

Mouse Monoclonal Antibody to SARS-Cov2-NP2

E10-31942 100 μl
EUR 275
Description: Available in various conjugation types.

Mouse Monoclonal Antibody to SARS-Cov2-NP2

E10-31943 100 μl
EUR 275
Description: Available in various conjugation types.

Mouse Monoclonal Antibody to SARS-Cov2-NP1

E10-31963 100 μl
EUR 275
Description: Available in various conjugation types.

Mouse Monoclonal Antibody to SARS-Cov2-NP1

E10-31964 100 μl
EUR 275
Description: Available in various conjugation types.

SARS-CoV-2 Antigen Rapid Test

INCP-502H 25 Tests
EUR 8.75

SARS-CoV2 N Protein

0572-001 100 ug
EUR 395

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-1 1T
EUR 9.6
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-25 25T/kit
EUR 42
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-100g 100 µg
EUR 850

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-20g 20 µg
EUR 100

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-50g 50 µg
EUR 450

SARS-CoV-2 Antigen Rapid Test Kit

GF101A2 25 Test/kit Ask for price

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G 25 Tests/Kit
EUR 112.8
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody

abx137719-100tests 100 tests
EUR 1237.5

SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody

abx137720-100tests 100 tests
EUR 1237.5